29 Sep Cellular Origins
Edwin Stone, CEO
Oct. 6 | 3:45pm | FLW Ballroom G
Cambridge, United Kingdom
(Private)
Cellular Origins is enabling the manufacture of cell therapies at scale. Our platform, Constellation, combines mobile robotics, sterile fluid transfer, and proven bioprocess technologies to automate and orchestrate cell therapy manufacturing. Designed to integrate with existing processes and industry-leading tools, Constellation enables developers and manufacturers to scale from clinical production to commercial supply without changing their biology, redeveloping therapies, or replicating manufacturing infrastructure. By transforming isolated manufacturing steps into a coordinated, factory-scale operation, Constellation increases throughput, improves consistency, optimises facility utilisation, and reduces operational complexity. Manufacturers gain a flexible, future-ready platform that can evolve with changing processes and technologies, while maintaining regulatory confidence and operational control. Trusted by leading industry partners, Cellular Origins is helping the industry deliver more therapies to more patients through scalable, reliable, and commercially viable manufacturing.